Research from University of California in Diabetes Provides New InsightsDiabetesNewsRx.com
By a News Reporter-Staff News Editor at Insurance Weekly News -- A new study on Diabetes is now available. According to news reporting originating from Los Angeles, California, by VerticalNews correspondents, research stated, "Despite the rollout of Medicare Part D, cost-related nonadherence (CRN) among older adults remains a problem. To examine the rate and correlates of self-reported CRN among a population of older persons with diabetes. Cross-sectional."
Our news editors obtained a quote from the research from the University of California, "A total of 1264 Part D patients with diabetes, who entered the coverage gap in 2006. Initial administrative medication lists were verified in computer-assisted telephone interviews, in which participants brought their medication bottles to the phone. Medications were classified into cardiometabolic (diabetes, hypertension, cholesterol-lowering), symptom relief, and 'other.' Participants were asked if they had any CRN during 2006, and if so to which medication/s. We used the person-medication dyad as the unit of analysis, and tested a multivariate random effects logistic regression model to analyze the correlates of CRN. Approximately 16% of participants reported CRN. CRN was more frequent for cholesterol-lowering medications (relative risk, 1.54; 95% confidence interval, 1.01-2.32) compared with medications taken for symptom relief. CRN was reported less frequently with increasing age above 75 years, compared with patients between 65 and 69. In addition, compared with those with incomes of >=$40,000,CRN risk for those with incomes of <$25,000 was markedly higher (relative risk, 3.05; 95% confidence interval, 1.99-4.65). In summary, we found high rates of CRN among Medicare beneficiaries with diabetes, particularly those with lower incomes. We observed more frequent CRN for cholesterol-lowering medications as compared with medications for symptom relief."
According to the news editors, the research concluded: "Efforts to ensure medication affordability for this population will be important in boosting adherence to key medications."
For more information on this research see: Cost-related Nonadherence by Medication Type Among Medicare Part D Beneficiaries With Diabetes. Medical Care, 2013;51(2):193-198. Medical Care can be contacted at: Lippincott Williams & Wilkins, 530 Walnut St, Philadelphia, PA 19106-3621, USA. (Lippincott Williams and Wilkins - www.lww.com; Medical Care - journals.lww.com/lww-medicalcare/pages/default.aspx)
The news editors report that additional information may be obtained by contacting J. Williams, University of California, David Geffen Sch Med, Div Gen Internal Med Hlth Serv Res, Los Angeles, CA 90024, United States.
Keywords for this news article include: Diabetes, Medicare, California, Los Angeles, Cholesterol, United States, Health Policy, North and Central America,
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2013, NewsRx LLC